Apolipoprotein F overexpression inhibits plasma PLTP activity and reduces HDL-cholesterol levels in mice

被引:0
|
作者
Lagor, William R. [1 ]
Billheimer, Jeffrey T. [1 ]
Rader, Daniel J. [1 ]
机构
[1] Univ Penn, Philadelphia, PA 19104 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P341
引用
收藏
页码:E95 / E95
页数:1
相关论文
共 50 条
  • [1] Overexpression of Apolipoprotein F Reduces HDL Cholesterol Levels In Vivo
    Lagor, William R.
    Brown, Robert J.
    Toh, Sue-Anne
    Millar, John S.
    Fuki, Ilia V.
    de la Llera-Moya, Margarita
    Yuen, Tiffany
    Rothblat, George
    Billheimer, Jeffrey T.
    Rader, Daniel J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (01) : 40 - U115
  • [2] Overexpression of Apolipoprotein O Does Not Impact Plasma HDL-Cholesterol Levels or HDL Functionality in Human Apolipoprotein A-I Transgenic Mice
    de Boer, Jan F.
    Nijstad, Niels
    Toelle, Markus
    Annema, Wytske
    van der Giet, Markus
    Tietge, Uwe J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E33 - E33
  • [3] Overexpression of apolipoprotein AV in the liver reduces plasma triglyceride and cholesterol but not HDL in ApoE deficient mice
    Huang, Wei
    Bi, Nan
    Zhang, Xiaohong
    Wang, Yanan
    Chen, Baosheng
    Liu, George
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 346 (01) : 14 - 18
  • [4] Sources of variability of plasma HDL-cholesterol levels
    Bove, Marilisa
    Cicero, Arrigo F. G.
    Manca, Marco
    Georgoulis, Ioannis
    Motta, Roberto
    Incorvaia, Loredana
    Giovannini, Marina
    Poggiopollini, Guido
    Gaddi, Antonio V.
    FUTURE LIPIDOLOGY, 2007, 2 (05): : 557 - 569
  • [5] Intestinal Regulation of Plasma HDL-Cholesterol Levels in Atherosclerosis-Resistant Mice
    Sontag, Timothy J.
    Reardon, Catherine A.
    Getz, Godfrey S.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E72 - E72
  • [6] Therapeutic approaches to raising plasma HDL-cholesterol levels
    Thompson, M. M.
    Reed, S. C.
    Cockerill, G. W.
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2004, 1 (02): : 84 - 89
  • [7] Therapeutic approaches to raising plasma HDL-cholesterol levels
    MM Thompson
    SC Reed
    GW Cockerill
    Nature Clinical Practice Cardiovascular Medicine, 2004, 1 : 84 - 89
  • [8] PLASMA-TRIGLYCERIDES IN REGULATION OF HDL-CHOLESTEROL LEVELS
    SCHAEFER, EJ
    ANDERSON, DW
    BREWER, HB
    LEVY, RI
    DANNER, RN
    BLACKWELDER, WC
    LANCET, 1978, 2 (8086): : 391 - 393
  • [9] Apolipoprotein E Mimetic Peptide Reduces Plasma Cholesterol, Increases Paraoxanase Levels and Activity, and Inhibits Atherosclerosis in Apoe Null Mice
    Nayyar, Gaurav
    Chaddha, Manjula
    Handattu, Shaila P.
    Garber, David W.
    Datta, Geeta
    Mayakonda, Palgunachari
    Monroe, Candyce E.
    Anantharamaiah, G. M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E111 - E111
  • [10] APOLIPOPROTEIN A-I GENE LOCUS HAPLOTYPES AND HDL-CHOLESTEROL LEVELS
    ANDERSON, RA
    ELIASON, SE
    CLINICAL RESEARCH, 1986, 34 (04): : A889 - A889